COLLEGIUM PHARMACEUTICAL INC's ticker is COLL and the CUSIP is 19459J104. A total of 197 filers reported holding COLLEGIUM PHARMACEUTICAL INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $287,667 | -82.4% | 12,871 | -81.1% | 0.03% | -88.9% |
| Q1 2023 | $1,634,631 | +565.1% | 68,138 | +543.2% | 0.30% | +416.9% |
| Q4 2022 | $245,781 | +33.6% | 10,594 | -7.5% | 0.06% | +40.5% |
| Q3 2022 | $184,000 | -82.5% | 11,455 | -77.9% | 0.04% | -85.2% |
| Q1 2022 | $1,054,000 | +463.6% | 51,753 | +417.5% | 0.28% | +343.8% |
| Q4 2021 | $187,000 | -9.7% | 10,000 | -15.6% | 0.06% | -75.6% |
| Q2 2020 | $207,000 | -15.2% | 11,855 | -0.2% | 0.26% | +249.3% |
| Q4 2019 | $244,000 | +110.3% | 11,875 | +17.4% | 0.08% | +70.5% |
| Q3 2019 | $116,000 | – | 10,111 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management LP | 2,606,500 | $51,452,000 | 1.44% |
| Camber Capital Management LP | 2,000,000 | $39,480,000 | 1.22% |
| Eventide Asset Management | 2,629,593 | $51,908,000 | 0.68% |
| GREAT POINT PARTNERS LLC | 121,342 | $2,395,000 | 0.56% |
| RICE HALL JAMES & ASSOCIATES, LLC | 753,038 | $14,865,000 | 0.55% |
| Values First Advisors, Inc. | 41,773 | $825,000 | 0.53% |
| CLARK ESTATES INC/NY | 183,800 | $3,628,000 | 0.52% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 710,398 | $14,023,000 | 0.48% |
| EMERALD ADVISERS, LLC | 590,256 | $11,652,000 | 0.42% |
| ACORN FINANCIAL ADVISORY SERVICES INC /ADV | 68,812 | $1,358,000 | 0.42% |